Advancing the life sciences through the power of 3D genomes, Arima Genomics is structured around developing innovative solutions designed to drive discovery in genomics and improve human health. A biotechnology company focued on commercializing a new standard of DNA sequencing, the company's sequencing platform enables de novo chromosome-spanning assembly of haplotype resolved genomes, identification of structural variants—providing critical genetic information that is otherwise unattainable with conventional sequencing. The company is leveraging low-cost sequencing short-read technologies - providing unparalleled access to the spatial and temporal changes in the 3D structure of the genome that alters gene regulation and cellular function. .
